Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology: Basic, Translational & Therapy: Special Session

  • You have access
    Regional 213Bi-DOTATOC peptide receptor alpha-therapy in patients with neuroendocrine liver metastases refractory to beta-radiation
    Clemens Kratochwil, Frederik Giesel, Alfred Morgenstern, Frank Bruchertseifer, Walter Mier, Christian Zechmann, Christos Apostolidis and Uwe Haberkorn
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 29;
  • You have access
    Imaging prostate cancer PC-3 xenografts pretargeted with bispecific Bombesin-anti-DTPA-Fab′ complexes and targeting with Tc-99m labeled polymers
    Vishwesh Patil, Keyur Gada, Rajiv Panwar, Yared Tekabe, Stan Majewski, Alexandra Varvarigou, Andrew Weisenberger and Ban-An Khaw
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 30;
  • You have access
    In-vivo proliferation imaging for early response assessment in patients with aggressive non-Hodgkins lymphoma
    Ken Herrmann, Ivan Santi, Ulrich Keller, Tibor Schuster, Martina Rudelius, Hans-Jürgen Wester, Christian Peschel, Markus Schwaiger, Tobias Dechow and Andreas Buck
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 32;
  • You have access
    Combined 18F NaF and 18F FDG PET/CT: Initial results of a multi-center trial
    Andrei Iagaru, Erik Mittra, Machaba Sathekge, Vineet Prakash, Victor Iyer, David Dick, Paula Lapa, Jorge Isidoro, Joao de Lima and Sanjiv Gambhir
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 34;
  • You have access
    Positron emission tomography with 2-[18F]-fluoro-2-desoxy-D-glucose after two cycles of R-CHOP predicts event free survival in diffuse large B-cell lymphoma: Partial results from multi-center IAEA-sponsored study
    Juliano Cerci, Jose Meneghetti, Francisca Redondo, Juliana Pereira, Patricia Fardella, Diana Paez, Renata Costa, Rose-Ann Padua, Stefano Fanti and Maurizio Dondi
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 28;
  • You have access
    Response and long-term control of bone metastases after peptide receptor radionuclide therapy with Lu177-DOTA octreotate
    Samer Ezziddin, Amir Sabet, Florian Heinemann, Charlotte Yong-Hing, Hojjat Ahmadzadehfar, Stefan Guhlke, Tobias Höller, Winfried Willinek and Hans Biersack
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 31;
  • You have access
    Comparison of four different imaging response criteria in patients with Hodgkin and non-Hodgkin lymphoma using PET/CT
    Guido Davidzon and Erik Mittra
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 33;
SNMMI

© 2025 SNMMI

Powered by HighWire